[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100582223":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":24,"locations":33,"responsibleParty":122,"collaborators":10,"id":124,"slug":125,"hasResults":126,"nctId":127,"briefTitle":128,"officialTitle":129,"acronym":10,"eligibilityCriteria":130,"healthyVolunteers":126,"sex":131,"minAge":132,"maxAge":133,"enrollmentInfo":134,"targetDuration":10,"studyType":137,"phases":10,"briefSummary":138,"conditions":139,"keywords":10,"overallStatus":36,"whyStopped":10,"lastUpdateSubmitDate":141,"lastUpdatePostDateStruct":142,"startDateStruct":145,"completionDateStruct":147,"leadSponsor":149,"locationsCount":150},{"fullName":5,"class":6},"GentiBio, Inc","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"all participants",null,"aged ≥ 18 to ≤ 55 years recently (within 6 months of the study visit) diagnosed with T1D",[13],"Other: blood draw or cheek swab",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"OTHER","blood draw or cheek swab","a blood draw or cheek swab for testing of HLA-DRB1\\*04:01",[9],[21],{"name":22,"affiliation":5,"role":23},"Mark Bach, MD","STUDY_DIRECTOR",[25,30],{"name":26,"role":27,"phone":28,"phoneExt":10,"email":29},"Kristin M Neff, MS","CONTACT","85-732-75483","kristin.neff@gentibio.com",{"name":22,"role":27,"phone":31,"phoneExt":10,"email":32},"908-578-3634","mark.bach@gentibio.com",[34,56,73,90,105],{"facility":35,"status":36,"city":37,"state":38,"zip":39,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"University of California, San Francisco","RECRUITING","San Francisco","California","94158","United States","US",{"type":43,"coordinates":44},"Point",[45,46],-122.41942,37.77493,{"lat":46,"lon":45},[49,53],{"name":50,"role":27,"phone":51,"phoneExt":10,"email":52},"Rebecca Wesch, Recruitment Coordinator","844-813-8273","clinicalresearch@diabetes.ucsf.edu",{"name":54,"role":55,"phone":10,"phoneExt":10,"email":10},"Stephen Gitelman, MD","PRINCIPAL_INVESTIGATOR",{"facility":57,"status":36,"city":58,"state":59,"zip":60,"country":40,"countryCode":41,"cosmosGeoPoint":61,"geoPoint":65,"contacts":66},"University of Florida- Gainesville","Gainesville","Florida","32610",{"type":43,"coordinates":62},[63,64],-82.32483,29.65163,{"lat":64,"lon":63},[67,71],{"name":68,"role":27,"phone":69,"phoneExt":10,"email":70},"Jennifer Hosford","352-294-5759","jennifer.hosford@peds.ufl.edu",{"name":72,"role":55,"phone":10,"phoneExt":10,"email":10},"Michael Haller, MD",{"facility":74,"status":36,"city":75,"state":76,"zip":77,"country":40,"countryCode":41,"cosmosGeoPoint":78,"geoPoint":82,"contacts":83},"Joslin Diabetes Center","Boston","Massachusetts","02215",{"type":43,"coordinates":79},[80,81],-71.05977,42.35843,{"lat":81,"lon":80},[84,88],{"name":85,"role":27,"phone":86,"phoneExt":10,"email":87},"Michelle Zhang","888-813-8669","T1DTrials@joslin.harvard.edu",{"name":89,"role":55,"phone":10,"phoneExt":10,"email":10},"Jason Gaglia, MD",{"facility":91,"status":36,"city":92,"state":92,"zip":93,"country":40,"countryCode":41,"cosmosGeoPoint":94,"geoPoint":98,"contacts":99},"Icahn School of Medicine at Mount Sinai","New York","10029",{"type":43,"coordinates":95},[96,97],-74.00597,40.71427,{"lat":97,"lon":96},[100,104],{"name":101,"role":27,"phone":102,"phoneExt":10,"email":103},"Carol Levy, MD","212-241-0068","carol.levy@mssm.edu",{"name":101,"role":55,"phone":10,"phoneExt":10,"email":10},{"facility":106,"status":36,"city":107,"state":108,"zip":109,"country":40,"countryCode":41,"cosmosGeoPoint":110,"geoPoint":114,"contacts":115},"University of North Carolina at Chapel Hill","Chapel Hill","North Carolina","27514",{"type":43,"coordinates":111},[112,113],-79.05584,35.9132,{"lat":113,"lon":112},[116,120],{"name":117,"role":27,"phone":118,"phoneExt":10,"email":119},"Alex Kass","984-974-3004","uncdiabetes@med.unc.edu",{"name":121,"role":55,"phone":10,"phoneExt":10,"email":10},"Klara Klein, MD",{"type":123,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100582223","hla-demographics-study-in-adults-with-type-1-diabetes-100582223",false,"NCT06860516","HLA Demographics Study in Adults With Type 1 Diabetes","A Non-interventional Study of HLA-DRB1*04:01 Distribution in Adults With Recently Diagnosed Type 1 Diabetes (T1D)","Inclusion Criteria:\n\n1. Male and female participants aged ≥ 18 to ≤ 55 years, with type 1 DM meeting American Diabetes Association criteria at diagnosis:\n\n   1. Fasting glucose ≥ 126 mg\u002FdL (7.0 mmol\u002FL), or\n   2. 2-hour oral glucose tolerance test plasma glucose ≥ 200 mg\u002FdL (11.0 mmol\u002FL), or\n   3. Hemoglobin A1c ≥ 6.5%, or\n   4. Random plasma glucose ≥ 200 mg\u002FdL (11.1 mmol\u002FL) (with documented classic hyperglycemia symptoms or hyperglycemic crisis).\n2. Date of T1D diagnosis within 6 months of the study visit.\n3. Able and willing to provide written, informed consent as approved by the institutional review board (IRB). Participants must be able to consent directly; no other person or guardian may consent for them in this study.\n\nExclusion Criteria:\n\n1. Participant is an employee of, or an immediate family member of an employee, of the Sponsor, study site, or of a contractor\u002Fvendor who is involved in direct study conduct for this protocol.\n2. Participant is unwilling or unable to comply with the study visit assessments.","ALL","18 Years","55 Years",{"count":135,"type":136},200,"ESTIMATED","OBSERVATIONAL","This is a study to evaluate the HLA-DRB1\\*04:01 genotype in adults that have been diagnosed with type 1 diabetes",[140],"Diabetes Mellitus, Type I","2026-04-30",{"date":143,"type":144},"2026-05-06","ACTUAL",{"date":146,"type":144},"2025-06-06",{"date":148,"type":136},"2027-03",{"name":5,"class":6},5]